ACM
HALO icon

Aster Capital Management’s Halozyme HALO Stock Holding History

Aster Capital Management’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,566
Closed -$173K – 1052
2025
Q4 		$173K Buy
2,566
+742
+41% +$49.9K 0.08% 249
2025
Q3 		$134K Sell
1,824
-7,030
-79% -$467K 0.07% 328
2025
Q2 		$461K Buy
+8,854
New +$504K 0.1% 230

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Aster Capital Management's HALO Position: Q1 2026 in Review

Aster Capital Management sold out of Halozyme (HALO) in Q1 2026, closing a stake of 2,566 shares — an estimated $173K sold.

Aster Capital Management first reported a position in HALO in Q2 2025 and held it in 3 quarters. The position peaked at $461K in Q2 2025. 635 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • Aster Capital Management reported no remaining Halozyme position as of Q1 2026 after selling out during the quarter.
  • Aster Capital Management sold 2,566 Halozyme shares in Q1 2026, an estimated $173K.
  • Aster Capital Management first reported a position in Halozyme in Q2 2025 and held it in 3 quarters.
  • Aster Capital Management's Halozyme position peaked at $461K in Q2 2025.
  • 635 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Aster Capital Management's 13F filing for Q1 2026, filed 13 May 2026.